Synopsys (SNPS) Cash & Equivalents (2009 - 2025)

Synopsys (SNPS) has 17 years of Cash & Equivalents data on file, last reported at $3.0 billion in FY2025.

• Quarterly Cash & Equivalents fell 41.78% year-over-year to $2.1 billion in Q1 2026, while the trailing twelve-month figure through Jan 2026 was $2.1 billion (down 41.78% YoY) and the FY2025 annual result came in at $3.0 billion, down 24.05% from the prior year.
• Cash & Equivalents retreated to $3.0 billion in FY2025, from $3.9 billion in the prior year.
• In the past five years, Cash & Equivalents ranged from a high of $3.9 billion in FY2024 to a low of $1.4 billion in FY2022.
• A 5-year average of $2.2 billion and a median of $1.4 billion in 2021 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2024 — Cash & Equivalents jumped 171.88% — and 2025, when it slipped 24.05%.
• Tracing SNPS's Cash & Equivalents over 5 years: stood at $1.4 billion in 2021, then retreated by 1.07% to $1.4 billion in 2022, then grew by 0.99% to $1.4 billion in 2023, then jumped by 171.88% to $3.9 billion in 2024, then fell by 24.05% to $3.0 billion in 2025.
• The last three Cash & Equivalents figures came in at $3.0 billion (FY2025), $3.9 billion (FY2024), and $1.4 billion (FY2023), per Business Quant data.